Conclusion: In adults with overweight and obesity, phentermine-topiramate and GLP-1 receptor agonists proved the best drugs in reducing weight; of the GLP-1 agonists, semaglutide might be the most effective.
PubMed 38582569 ↗Topiramate
The short answer. There isn't much data on Topiramate yet — 14 mentions, 10 with a clear outcome — so treat these numbers as anecdotal. It is most often used for focus: 0% of 5 reports say that improved. It is well studied — 382 meta-analyses on PubMed. The most common complaint is brain fog.
From 14 mentions in total — the rest didn't say how it went and aren't counted.
What Topiramate does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 382 meta-analyses on PubMed ↗ · 405 randomized trials ↗
Conclusion: Finding of this systematic review and network meta-analysis suggest that combining lifestyle treatment with obesity management medications was associated with the greatest short-term (typically 6 to 12 months) weight reduction in adolescents with obesity. HBLT remained an indispensable component of any effective weight management, delivering meaningful weight loss and healthier body composition on its own. Combined with lifestyle treatment, pharmacotherapy was a key component, not solely an adjunct, associated with the greatest BMI and BMI z score improvements, and long-term sustainability and
PubMed 42329656 ↗Conclusion: Cognitive behavioral therapy, lisdexamfetamine, SGAs, and topiramate reduced binge eating and related psychopathology, and lisdexamfetamine and topiramate reduced weight in adults with binge-eating disorder.
PubMed 27367316 ↗Conclusion: In conclusions, these antipsychotics, carbamazepine, lithium, tamoxifen, and valproate were effective for acute mania. However, only aripiprazole, olanzapine, quetiapine, and risperidone had better acceptability than the placebo.
PubMed 34642461 ↗340 human trials on ClinicalTrials.gov test Topiramate — 226 completed, 14 recruiting now. See all on ClinicalTrials.gov ↗
- Retrospective Evaluation of Sibutramine-Topiramate Therapy for Obesity in Real-World Outpatient Practice · Obesity & Overweight · 2026
- Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP · Obesity, Childhood · 2024
- Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest · Status Epilepticus, Cardiac Arrest · 2025
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
The current US prescription label has no boxed warning.
7 recalls of products named for Topiramate. Most recent:
- 2024-01-10 · Class III: Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability… record ↗
- 2021-12-01 · Class III: Discoloration record ↗
- 2020-08-26 · Class II: CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches. record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
91,067 adverse-event reports mention Topiramate. Most often reported:
- Drug ineffective · 10,334
- Off label use · 7,472
- Headache · 6,530
- Nausea · 5,931
- Fatigue · 5,424
- Pain · 4,615
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Topiramate C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗
NIH has funded 34 research projects with Topiramate in the title, $55,844,155 in total (1990–2026). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Topiramate ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“I also take topiramate for eating compulsion from anxiety from the beginning which always seemed to help.”
“My guess is this is from an anti-epileptic I was taking - one that messes with glutamate and causes 'brain slowing'. It's called Topiramate - AKA Dopamax. Among other things, it's an NMDAr antagonist and also messes with AMPA.”
Other options for focus
Sources
- User reports: 14 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate